Rocket Lab's Q3 2026 earnings, due after the November 9 close, face a 72.5% market-implied probability of missing consensus estimates, reflecting persistent net losses and elevated costs tied to Neutron development. Q2 results showed revenue of $234 million (up 62% year-over-year) beating targets modestly while EPS of -$0.08 missed estimates, with guidance pointing to $250–265 million revenue and continued adjusted EBITDA losses of $17–23 million. Analyst forecasts center on roughly $257 million revenue and a -$0.07 EPS loss, amid a record $2.36 billion backlog but ongoing cash burn and a Neutron first-flight delay into 2027. High valuation multiples relative to current profitability and sector growth benchmarks reinforce trader caution on near-term beats.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено1H6H1D7D30DALL
View resolved

Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы